Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis
Clinical & Translational Immunology · 2026-06 · 15 (6)
DOI: 10.1002/cti2.70112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Translational Immunology, online erschienen am 21.06.2026. Verfasst von Merve Çebi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Istanbul Medical Faculty Istanbul University Istanbul Turkey. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu, Istanbul Üniversitesi.
Abstract (Originalsprache)
Objectives
T follicular helper (Tfh) cells regulate B‐cell responses within germinal centres primarily via programmed cell death protein 1 (PD‐1) and inducible T‐cell costimulator (ICOS), whereas CXC chemokine receptor type 5 (CXCR5)‐negative T peripheral helper (Tph) cells provide similar support extra‐follicularly. Both subsets contribute to the pathogenesis of acetylcholine receptor‐antibody‐positive myasthenia gravis (AChR‐MG). This study investigated the roles of PD‐1, ICOS and CXCR5 in T‐cell‐mediated B‐cell activation to identify therapeutic targets for MG.
Methods
CD4 T cells from 10 healthy controls and six untreated AChR‐MG patients were sorted by CXCR5, PD‐1 and ICOS expression, stimulated with anti‐CD3/CD28, and co‐cultured with autologous CD19 B cells. Plasmablast differentiation, total AChR‐IgG and cytokine productions were measured.
Results
In healthy donors, PD‐1 + or ICOS + Tph cells modestly enhanced plasmablasts and IgG production, while CXCR5 + Tfh cells co‐expressing PD‐1 or ICOS induced significantly stronger B‐cell responses. In AChR‐MG patients, PD‐1 expressing T cells promoted plasmablasts, antibody production and cytokine secretion regardless of CXCR5, with amplified effects in CXCR5 + co‐cultures.
Conclusions
PD‐1 expression on CD4 + T cells is associated with increased B‐cell helper capacity. This effect is more pronounced in Tfh‐related contexts and is linked to dysregulated humoral immune responses in MG. PD‐1 appears to play a central role in the pathogenesis of MG, primarily through Tfh cell activity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, Istanbul Medical Faculty Istanbul University Istanbul Turkey.
- Present address: M Çebi, Department of Medical Biology School of Medicine, Recep Tayyip Erdoğan University Rize Turkey.
- Department of Neurology, Istanbul Medical Faculty Istanbul University Istanbul Turkey.
ORCID-Profile: Merve Çebi, Arman Çakar, Hacer Durmuş, Yeşim Parman, Güher Saruhan-Direskeneli
Förderung
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
- Istanbul Üniversitesi
Zitieren
APA
Çebi, M., Çakar, A., Durmuş, H., Parman, Y., & Saruhan-Direskeneli, G. (2026). Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis. Clinical & Translational Immunology, 15(6). https://doi.org/10.1002/cti2.70112
Vancouver
Çebi M, Çakar A, Durmuş H, Parman Y, Saruhan-Direskeneli G. Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis. Clinical & Translational Immunology. 2026;15(6). doi:10.1002/cti2.70112
BibTeX
@article{ebi2026,
author = {Çebi, Merve and Çakar, Arman and Durmuş, Hacer and Parman, Yeşim and Saruhan-Direskeneli, Güher},
title = {Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravis},
journal = {Clinical & Translational Immunology},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/cti2.70112}
}
EUVIMED